GLP-1s 获 FDA 黑框警告,提示罕见眼病风险
STAT+: GLP-1s are given an FDA warning for rare eye condition risk
FDA 对 GLP-1 类药物发出黑框警告,提示使用这些药物可能引发罕见眼病风险。原文未提供具体药物名称和详细数据。
WuXi removed from Trump’s chinese military list, the new Space Race, and more biotech news
![]()
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got lots of news that we’ll get straight into.
The need-to-know this morning
- Beam Therapeutics said its CRISPR-based treatment for sickle cell disease achieved the primary goal of a pivotal clinical trial — freedom from severe pain crises for at least 12 months. No detailed data were disclosed, but Beam said it would file an FDA marketing application for the therapy, called risto-cel, as soon as the end of this year.
PepGen shows promising data for muscular dystrophy
The biotech company PepGen said this morning that its experimental drug had shown, by one key measure, the most promising early data yet in the race to treat a commmon type of muscular dystrophy.
STAT+ Exclusive Story
Already have an account? Log in

This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
National Biotech Reporter
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.
来源:STAT 主站 · statnews.com